Pharmacological Management of Treatment-Resistant Anorexia Nervosa
Only 13% to 50% of AN patients are considered recovered 1 to 2 years posttreatment, and 20% to 30% go on to develop a chronic and unremitting course of AN. How can we improve these outcomes?
Reducing Heterogeneity in Non–Treatment-Resistant and Treatment-Resistant Schizophrenia
Treatment-Resistant OCD: Strategies and Novel Treatment Options
OCD is highly comorbid and warrants consideration in difficult to treat cases. Learn more here.
The Current State of the Art and the Not Too Distant Future
Put treatment resistance in perspective with Sheldon H. Preskorn, MD.
Mania With Psychosis vs Schizophrenia vs Schizoaffective Disorder, Bipolar Type
Have you had difficulty with differential diagnosis when patients have manic symptoms and psychosis? One doctor discusses the related DSM-5 criteria changes and some of their implications for psychopharmacology.
5 Crypto Investing Rules for Busy Doctors
Cryptocurrency can be complicated, but with these 5 tips, you can plan your best investment moves.
What Can Philosophy Learn From Madness?
Wouter Kusters, PhD, uses his experiences with psychosis to better inform his philosophy. What can we learn from him?
"...barriers that create space for healing placed close enough to hear everyone’s cries of longing and love..."
Doorknob Moments: Why They Happen and How to Use Them
Expect the unexpected: how doorknob moments provide valuable new material to help you move treatment forward.
Advances in Treatments for ADHD
What treatments were recently approved by the US Food and Drug Administration for pediatric patients with ADHD?
Chatbots for Child Mental Health Care: Helpful, but Limited
An estimated 7.7 million children have at least 1 mental health disorder. How can chatbots help?
Delirium: Don’t Miss It
Delirium: an underrecognized, underdiagnosed medical condition.
Lyme Disease in Psychiatry: Controversies, Chronic Symptoms, and Recent Developments
In this CME article, learn more about the controversies surrounding Lyme disease diagnosis and treatment, and common neuropsychiatric presentations of and treatment options.
Hope for the New Year
The glass is half full: reflections on where we are and hope for where we are heading in psychiatry.
In Memoriam: Michael J. Hennessy Sr
Paying tribute to a man who believed in family and health care equity.
The Goldwater Rule Is Fine, if Refined. Here’s How to Do it.
How can we better define, clarify, and expand the Goldwater Rule for ethical and effective use in today's society?
This Is the Water: The Social Determinants of Mental Health and the Future of Psychiatry
Here's why we need more effective training, practice, and advocacy regarding the social determinants of mental health.
2 Commerce Drive Cranbury, NJ 08512